Activation of Oncogenic and Immune-Response Pathways Is Linked to Disease-Specific Survival in Merkel Cell Carcinoma

SIMPLE SUMMARY: Merkel cell carcinoma (MCC) is a rare and aggressive skin cancer. Developing targeted therapies for MCC requires increased understanding of the mechanisms driving tumor progression. In this study, we aimed to identify genes, signaling pathways, and processes that play crucial roles i...

Descripción completa

Detalles Bibliográficos
Autores principales: Sundqvist, Benjamin, Kilpinen, Sami, Böhling, Tom, Koljonen, Virve, Sihto, Harri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331388/
https://www.ncbi.nlm.nih.gov/pubmed/35892849
http://dx.doi.org/10.3390/cancers14153591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331388/
https://www.ncbi.nlm.nih.gov/pubmed/35892849
http://dx.doi.org/10.3390/cancers14153591

Ejemplares similares